These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6119772)

  • 1. The pharmacokinetics of ranitidine in patients with chronic duodenal ulceration.
    McFadyen ML; Folb PI; Marks IN; Wright JP; Lucke W
    Scand J Gastroenterol Suppl; 1981 Jun; 69():109-13. PubMed ID: 6119772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placebo controlled studies with ranitidine in duodenal ulcer.
    Dobrilla G; Barbara L; Bianchi Porro G; Felder M; Mazzacca G; Miglioli L; Pera A; Petrillo M; Sabbatini F; Verme G
    Scand J Gastroenterol Suppl; 1981 Jun; 69():101-7. PubMed ID: 6119771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and gastric secretory studies of ranitidine in man.
    Louis WJ; Mihaly GW; Hanson RG; Anderson A; McNeil JJ; Yeomans ND; Smallwood RA
    Scand J Gastroenterol Suppl; 1981 Jun; 69():11-7. PubMed ID: 6119773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of ranitidine in patients with chronic duodenal ulceration: a comparison of responders and non-responders.
    McFadyen ML; Folb PI; Miller R; Marks IN; Moshal MG
    Eur J Clin Pharmacol; 1983; 24(4):441-7. PubMed ID: 6305671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of duodenal ulcer with H2-blockers. 2 x 150 mg ranitidine versus 2 x 400 mg cimetidine].
    Hüttemann W
    Fortschr Med; 1983 Jan; 101(4):139-41. PubMed ID: 6131857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and endocrine aspects of treatment with ranitidine.
    Boyd EJ; Peden NR; Browning MC; Saunders JH; Wormsley KG
    Scand J Gastroenterol Suppl; 1981 Jun; 69():81-3. PubMed ID: 6119787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind endoscopically controlled trial of ranitidine in a high incidence area.
    Moshal MG; Spitaels JM; Khan F
    Scand J Gastroenterol Suppl; 1981 Jun; 69():129-31. PubMed ID: 6119777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ranitidine in the treatment of duodenal ulcer. Initial clinical experience with 33 patients].
    Noya G; Dettori G; Antona C; Niolu P; Muscas A; Marongiu G; Biglioli P
    Minerva Med; 1983 Mar; 74(13):691-3. PubMed ID: 6132353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranitidine and cimetidine for duodenal ulcer.
    Langman MJ; Henry DA; Ogilvie A
    Scand J Gastroenterol Suppl; 1981 Jun; 69():115-7. PubMed ID: 6119774
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of ranitidine hydrochloride, a new histamine H2-receptor antagonist, on intrinsic factor secretion.
    Mohammed R; Clark JS; Adams JF; Hearns JB; Crean GP
    Clin Ther; 1981; 4(2):118-20. PubMed ID: 6117373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of ranitidine and cimetidine on the twenty-four hour intragastric acidity profile and nocturnal acid secretion in duodenal ulcer patients.
    Walt RP; Malé PJ; Hunt RH; Rawlings J; Milton-Thompson GJ; Misiewicz JJ
    Scand J Gastroenterol Suppl; 1981 Jun; 69():33-7. PubMed ID: 6119780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of pirenzepine in patients with gastric or duodenal ulcers.
    Hayakawa A; Misawa T; Nishihara S; Kobayashi S; Bozler G
    Arzneimittelforschung; 1987 Aug; 37(8):980-2. PubMed ID: 3675700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranitidine: a new H2-receptor antagonist.
    Berner BD; Conner CS; Sawyer DR; Siepler JK
    Clin Pharm; 1982; 1(6):499-509. PubMed ID: 6309467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ranitidine, a newly developed histamine H2-receptor antagonist. First experimental and clinical results].
    Simon B; Dammann HG; Müller P; Kather H
    Dtsch Med Wochenschr; 1980 Dec; 105(50):1753-5. PubMed ID: 6108203
    [No Abstract]   [Full Text] [Related]  

  • 15. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
    Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of duodenal and gastric ulcer with ranitidine--a controlled, multicentre clinical trial.
    Gibinski K; Nowak A; Gabryelewicz A; Szalaj W; Hasik J; Klincewicz H; Pokora J; Radwan P; Kosecki P; Pachlewski J
    Dtsch Z Verdau Stoffwechselkr; 1982; 42(2-3):64-9. PubMed ID: 6286274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roxatidine versus ranitidine in the treatment of duodenal ulcer: a randomized, double blind, controlled, multicenter study in Thailand.
    Kachintorn U; Chinapak O; Vongphanich V; Kositchaiwat C; Lekhayananda S; Khow-ean U; Suttinont C; Saowaros V; Kludchareon N; Leethochawalit M
    J Med Assoc Thai; 1995 Dec; 78(12):641-7. PubMed ID: 8868007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ranitidine: a pilot study in Japan.
    Takemoto T; Okazaki Y; Okita K; Namiki M; Ishikawa M; Oshiba S; Kurokawa K
    Scand J Gastroenterol Suppl; 1981 Jun; 69():125-8. PubMed ID: 6119776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged bedtime treatment with H2-receptor antagonists (ranitidine and famotidine) does not affect blood alcohol levels after ethanol ingestion in male patients with duodenal ulcer.
    Casini A; Pizzigallo AM; Mari F; Bertol E; Surrenti C
    Am J Gastroenterol; 1994 May; 89(5):745-9. PubMed ID: 8172150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
    Poynard T; Lemaire M; Agostini H
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.